HIV-1 RNA levels, resistance, and drug diffusion in semen versus blood in patients receiving a lopinavir-containing regimen

J Acquir Immune Defic Syndr. 2003 Apr 1;32(4):462-4. doi: 10.1097/00126334-200304010-00018.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiretroviral Therapy, Highly Active
  • Genotype
  • HIV Protease Inhibitors / analysis
  • HIV Protease Inhibitors / blood
  • HIV Protease Inhibitors / therapeutic use
  • HIV-1 / genetics*
  • HIV-1 / isolation & purification
  • Humans
  • Lopinavir
  • Male
  • Mutation
  • Pyrimidinones / analysis
  • Pyrimidinones / blood
  • Pyrimidinones / therapeutic use*
  • RNA, Viral / blood*
  • Ritonavir / therapeutic use
  • Semen / chemistry*
  • Tissue Distribution

Substances

  • HIV Protease Inhibitors
  • Pyrimidinones
  • RNA, Viral
  • Lopinavir
  • Ritonavir